Yamo Pharmaceuticals

IAMA Therapeutics

This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.

Confluence Pharmaceuticals

This company develops therapeutic treatments for social and communication impairments in patients with Fragile X Syndrome and autism spectrum disorders.

Scioto Biosciences

This company develops live bacterial therapeutics and delivery platforms to treat patients with autism, gastrointestinal disorders and neonatal intestinal conditions.

Pharmasum Therapeutics

This company develops neurological drugs for patients with dementia, Alzheimer's disease and Down syndrome to provide to the global healthcare market.

DAMONA Pharmaceuticals

This company develops small molecule therapeutics to restore cognitive function for patients with neurological and psychiatric disorders.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Uncommon Therapeutics

This company develops gene-based medicines for patients with rare neurodevelopmental disorders, with an initial focus on treating Rett Syndrome.

Saol Therapeutics

This pharmaceutical company develops clinical-stage therapies for patients with central nervous system disorders, pain, spasticity and orphan diseases.